Structure-based screening using molecular docking is now widely used for ligand discovery. The technique makes many approximations and, although, it has had noteworthy successes, it is neither fully reliable nor do we understand why it fails when it does. Here, we develop model experimental systems where problems in docking may be isolated and understood. These systems are used to test new docking algorithms.
The specific aims are: 1. To develop model experimental systems to test docking algorithms. We introduce seven model binding sites of increasing complexity. A. Five buried cavities in T4 lysozyme and cytochrome C peroxiadase: one purely hydrophobic, three bearing a single polar, cationic, and anionic residue, respectively, and a fifth that is anionic with several polar groups. These isolate polar, apolar, and ionic terms in docking scoring functions. B. A hydrophobic cavity in TEM-1, open to solvent at one end, that explores the influence of the protein-solvent interface in docking. C. AmpC B-lactamase, which has all the complexities of a drug-binding site, but is a system over which we have complete control. New docking methods will be tested experimentally against these model systems. Predicted geometries will be tested by crystallography and binding energies determined. In these systems, we expect to learn as much from """"""""decoy"""""""" molecules that do not bind, as from those that do. These provide strong decoy sets for docking. Both the model systems and the decoys should be useful to the community. 2. To develop new docking algorithms. The docking problem is one of sampling available states, which grow exponentially with degrees of freedom, and evaluating their energies, difficult in condensed phases. To improve the energetic component in docking, we consider algorithms to A. calculate context-dependent ligand desolvation and B. receptor desolvation in docking. These key terms are often overlooked, owing to their high computational cost; the new methods should overcome this cost, albeit with important approximations. We also consider sampling C. receptor flexibility with an algorithm that scales only linearly with degrees of freedom, overcoming an otherwise exponential growth. This is extended to D. evaluate docking to homology models. All methods are tested experimentally against our model binding sites. Finally, we E. use the extensive sets of decoys developed in aim 1 to evaluate and improve docking algorithms.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM059957-09
Application #
7217284
Study Section
Molecular and Cellular Biophysics Study Section (BBCA)
Program Officer
Preusch, Peter C
Project Start
1999-08-01
Project End
2009-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
9
Fiscal Year
2007
Total Cost
$269,590
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Wang, Sheng; Che, Tao; Levit, Anat et al. (2018) Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. Nature 555:269-273
McCorvy, John D; Butler, Kyle V; Kelly, Brendan et al. (2018) Structure-inspired design of ?-arrestin-biased ligands for aminergic GPCRs. Nat Chem Biol 14:126-134
Wacker, Daniel; Wang, Sheng; McCorvy, John D et al. (2017) Crystal Structure of an LSD-Bound Human Serotonin Receptor. Cell 168:377-389.e12
Wang, Sheng; Wacker, Daniel; Levit, Anat et al. (2017) D4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Science 358:381-386
Manglik, Aashish; Lin, Henry; Aryal, Dipendra K et al. (2016) Structure-based discovery of opioid analgesics with reduced side effects. Nature 537:185-190
Lee, Hyelee; Fischer, Marcus; Shoichet, Brian K et al. (2016) Hydrogen Bonding of 1,2-Azaborines in the Binding Cavity of T4 Lysozyme Mutants: Structures and Thermodynamics. J Am Chem Soc 138:12021-4
Korczynska, Magdalena; Le, Daniel D; Younger, Noah et al. (2016) Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors. J Med Chem 59:1580-98
Irwin, John J; Shoichet, Brian K (2016) Docking Screens for Novel Ligands Conferring New Biology. J Med Chem 59:4103-20
Kincaid, Virginia A; London, Nir; Wangkanont, Kittikhun et al. (2015) Virtual Screening for UDP-Galactopyranose Mutase Ligands Identifies a New Class of Antimycobacterial Agents. ACS Chem Biol 10:2209-18
Merski, Matthew; Fischer, Marcus; Balius, Trent E et al. (2015) Homologous ligands accommodated by discrete conformations of a buried cavity. Proc Natl Acad Sci U S A 112:5039-44

Showing the most recent 10 out of 72 publications